microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Mutat Res
; 816-818: 111679, 2019 11.
Article
em En
| MEDLINE
| ID: mdl-31715522
ABSTRACT
Glioblastoma (GBM) is the most lethal type of primary brain tumor. Currently, even with optimal and multimodal cancer therapies, the survival rate of GBM patients remains poor. One reason for inadequate response of GBM tumors to radiotherapy is radioresistance (RR). Thus, there is a critical need for new insights about GBM treatment to increase the chance of treatment. microRNAs (miRNAs) are important regulatory molecules that can effectively control GBM radiosensitivity (RS) by affecting radiation-related signal transduction pathways such as apoptosis, proliferation, DNA repair and cell cycle regulation. miRNAs provide new clinical perspectives for developing effective GBM treatments. A growing body of literature has demonstrated that GBM RS can be modified by modulating the expression of miRNAs such as miR-7, miR-10b, miR-124, miR-128, miR-320, miR-21, miR-203, and miR-153. This paper highlights the miRNAs and the underlying molecular mechanisms that are involved in the RS of GBM. Besides highlighting the role of miRNAs in different signaling pathways, we explain the mechanisms that affect RS of GBM for modulating radiation response at the clinical level.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tolerância a Radiação
/
Neoplasias Encefálicas
/
Transdução de Sinais
/
Glioblastoma
/
MicroRNAs
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article